Literature DB >> 11576822

TOGA analysis of gene expression to accelerate target development.

D Lo1, B Hilbush, J G Sutcliffe.   

Abstract

With the availability of new technologies for analysis of gene expression, drug targets may now be identified through more focused rational approaches. We have developed an extremely sensitive, reproducible, and accurate method called TOGA, enabling analysis of nearly all genes within an RNA sample. This technology can be used to identify genes regulated in a great variety of situations. For example, we have been able to find genes with expression restricted to specific brain regions, and in a recent example, we found a gene regulated in specific brain regions in response to clozapine treatment. These studies will quickly lead to identification of genes critical to specific biological and clinical processes, accelerating the development of new targets and therapies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576822     DOI: 10.1016/s0928-0987(01)00174-9

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  2 in total

Review 1.  Expression profiling and QTL analysis: a powerful complementary strategy in drug abuse research.

Authors:  John Spence; Tiebing Liang; Tatiana Foroud; David Lo; Lucinda Carr
Journal:  Addict Biol       Date:  2005-03       Impact factor: 4.280

2.  Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway.

Authors:  Andreas G Bader; Katherine A Felts; Ning Jiang; Hwai Wen Chang; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.